1-5 of 5
William W. Grosh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)

Craig L. Slingluff, Jr, Gina R. Petroni, Kerrington R. Molhoek, David L. Brautigan, Kimberly A. Chianese-Bullock, Amber L. Shada, Mark E. Smolkin, Walter C. Olson, Alison Gaucher, Cheryl Murphy Chase, William W. Grosh, Geoffrey R. Weiss, Aubrey G. Wagenseller, Anthony J. Olszanski, Lainie Martin, Sofia M. Shea, Gulsun Erdag, Prahlad Ram, Jeffrey E. Gershenwald, Michael J. Weber
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (13): 3611–3620.
https://doi.org/10.1158/1078-0432.CCR-12-3919
Published: 30 June 2013
View articletitled, Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)
Open the PDF for Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47) in another window
Includes: Supplementary data
Journal Articles

Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma

Geoffrey R. Weiss, William W. Grosh, Kimberly A. Chianese-Bullock, Yingdong Zhao, Hui Liu, Craig L. Slingluff, Jr, Francesco M. Marincola, Ena Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7440–7450.
https://doi.org/10.1158/1078-0432.CCR-11-1650
Published: 30 November 2011
View articletitled, Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma
Open the PDF for Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma in another window
Journal Articles

Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial

Craig L. Slingluff, Jr., Gina R. Petroni, Walter C. Olson, Mark E. Smolkin, Merrick I. Ross, Naomi B. Haas, William W. Grosh, Marc E. Boisvert, John M. Kirkwood, Kimberly A. Chianese-Bullock
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (22): 7036–7044.
https://doi.org/10.1158/1078-0432.CCR-09-1544
Published: 11 November 2009
View articletitled, Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial
Open the PDF for Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial in another window
Includes: Supplementary data
Journal Articles

Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting

Craig L. Slingluff, Jr., Gina R. Petroni, Kimberly A. Chianese-Bullock, Mark E. Smolkin, Sarah Hibbitts, Cheryl Murphy, Naomi Johansen, William W. Grosh, Galina V. Yamshchikov, Patrice Y. Neese, James W. Patterson, Robyn Fink, Patrice K. Rehm
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (21): 6386–6395.
https://doi.org/10.1158/1078-0432.CCR-07-0486
Published: 01 November 2007
View articletitled, Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting
Open the PDF for Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting in another window
Journal Articles

Phase I Trial of a Melanoma Vaccine with gp100280–288 Peptide and Tetanus Helper Peptide in Adjuvant: Immunologic and Clinical Outcomes

Craig L. Slingluff, Jr., Galina Yamshchikov, Patrice Neese, Holly Galavotti, Shannon Eastham, Victor H. Engelhard, Dave Kittlesen, Donna Deacon, Sarah Hibbitts, William W. Grosh, Gina Petroni, Roger Cohen, Catie Wiernasz, James W. Patterson, Brian P. Conway, William G. Ross
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (10): 3012–3024.
Published: 01 October 2001
View articletitled, Phase I Trial of a Melanoma Vaccine with gp100280–288 Peptide and Tetanus Helper Peptide in Adjuvant: Immunologic and Clinical Outcomes
Open the PDF for Phase I Trial of a Melanoma Vaccine with gp100280–288 Peptide and Tetanus Helper Peptide in Adjuvant: Immunologic and Clinical Outcomes in another window